Synopsis of recent research by authors named "Wan-hai Xu"
- Wan-hai Xu's recent research emphasizes the role of peptides and cell death mechanisms in cancer therapy, with notable studies focusing on a novel endostatin peptide targeting PI3K-Akt signaling in prostate cancer and the potential of ferroptosis in bladder cancer treatment strategies.
- His work on microtubule-trapping peptides demonstrates innovative approaches in biomolecular condensation, aiming to enhance cellular interactions and therapeutic efficacy in cancer treatment through self-assembly processes.
- Xu's research also explores the mechanisms underlying renal cell carcinoma and prostate cancer, including the promotion of PKM2 conversion to combat tumor metabolism and resistance to chemotherapy, highlighting the importance of understanding metabolic pathways in cancer progression.